Vaxxinity, Inc.
US ˙ OTCPK ˙ US92244V1044

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Peter Powchik. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Peter Powchik har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:VAXX / Vaxxinity, Inc. Director 225.858
US:REGN / Regeneron Pharmaceuticals, Inc. SVP Clinical Development & Reg 5.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Peter Powchik. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb VAXX / Vaxxinity, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i VAXX / Vaxxinity, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VAXX / Vaxxinity, Inc. Insider Trades
Insidersalg VAXX / Vaxxinity, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i VAXX / Vaxxinity, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VAXX / Vaxxinity, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Peter Powchik som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-04-04 3 VAXX Vaxxinity, Inc.
Class A common stock
225.858
2022-04-04 2022-03-31 4 VAXX Vaxxinity, Inc.
Stock Option (right to buy)
A - Award 94.186 94.186
2016-12-19 2016-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 5.000 5.000
2016-12-19 2016-05-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift -2.459 34.765 -6,61
2016-12-19 2016-05-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift 2.459 2.459
2016-12-19 2016-05-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift 2.459 2.459
2016-12-19 2016-05-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift -2.459 0 -100,00
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 25.000 25.000
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -1.921 0 -100,00
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 1.921 17.742 12,14 52,03 99.950 923.116
2015-08-17 2015-08-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -1.500 15.821 -8,66 578,63 -867.945 9.154.505
2015-08-17 2015-08-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -2.258 17.321 -11,53 577,75 -1.304.560 10.007.208
2015-08-17 2015-08-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -2.004 19.579 -9,29 576,65 -1.155.607 11.290.230
2015-08-17 2015-08-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -700 21.583 -3,14 575,47 -402.829 12.420.369
2015-08-17 2015-08-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -900 22.283 -3,88 574,75 -517.275 12.807.154
2015-08-17 2015-08-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -2.717 23.183 -10,49 573,64 -1.558.580 13.298.696
2015-08-17 2015-08-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -2.800 25.900 -9,76 572,60 -1.603.280 14.830.340
2015-08-17 2015-08-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -5.598 28.700 -16,32 571,54 -3.199.481 16.403.198
2015-08-17 2015-08-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -3.603 34.298 -9,51 570,63 -2.055.980 19.571.468
2015-08-17 2015-08-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -1.405 37.901 -3,57 569,63 -800.330 21.589.547
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -10.000 30.000 -25,00
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -14.625 29.250 -33,33
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -8.000 6.079 -56,82
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -23.000 14.079 -62,03
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4.736 0 -100,00
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -2.146 39.306 -5,18 579,35 -1.243.285 22.771.931
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -250 41.452 -0,60 579,35 -144.838 24.015.216
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 4.736 41.702 12,81 30,63 145.064 1.277.332
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -3.755 36.966 -9,22 579,35 -2.175.459 21.416.252
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -718 40.721 -1,73 579,35 -415.973 23.591.711
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 8.000 41.439 23,92 52,03 416.240 2.156.071
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -10.795 33.439 -24,40 579,35 -6.254.083 19.372.885
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -2.065 44.234 -4,46 579,35 -1.196.358 25.626.968
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 23.000 46.299 98,72 52,03 1.196.690 2.408.937
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -5.210 23.299 -18,27 579,35 -3.018.414 13.498.276
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -4.521 28.509 -13,69 579,35 -2.619.241 16.516.689
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 14.625 33.030 79,46 179,13 2.619.776 5.916.664
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -2.749 18.405 -13,00 579,35 -1.592.633 10.662.937
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -4.667 21.154 -18,07 579,35 -2.703.826 12.255.570
2015-08-17 2015-08-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 25.821 63,21 270,43 2.704.300 6.982.773
2015-01-05 2015-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -300 10.711 -2,72 418,40 -125.520 4.481.482
2015-01-05 2015-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.000 11.011 -8,33 417,44 -417.440 4.596.432
2015-01-05 2015-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -900 12.011 -6,97 416,75 -375.075 5.005.584
2015-01-05 2015-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.642 12.911 -11,28 415,20 -681.758 5.360.647
2015-01-05 2015-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.758 14.553 -15,93 414,07 -1.142.005 6.025.961
2015-01-05 2015-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.700 17.311 -8,94 412,81 -701.777 7.146.154
2015-01-05 2015-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.122 19.011 -5,57 411,99 -462.253 7.832.342
2015-01-05 2015-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.400 20.133 -6,50 410,99 -575.386 8.274.462
2015-01-05 2014-12-31 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -25.000 37.079 -40,27
2015-01-05 2014-12-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -11.027 21.533 -33,87 412,78 -4.551.725 8.888.392
2015-01-05 2014-12-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -3.151 32.560 -8,82 412,78 -1.300.670 13.440.117
2015-01-05 2014-12-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 25.000 35.711 233,40 52,03 1.300.750 1.858.043
2014-12-22 2014-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -3.264 0 -100,00
2014-12-22 2014-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 3.264 10.711 43,83 30,63 99.976 328.078
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 34.000 34.000
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 48.000 62.079 340,93
2014-01-03 2014-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -100 25.447 -0,39 277,50 -27.750 7.061.542
2014-01-03 2014-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.296 25.547 -4,83 276,75 -358.668 7.070.132
2014-01-03 2014-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -6.893 26.843 -20,43 276,04 -1.902.744 7.409.742
2014-01-03 2014-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -3.777 33.736 -10,07 274,69 -1.037.504 9.266.942
2014-01-03 2014-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -5.602 37.513 -12,99 273,77 -1.533.660 10.269.934
2014-01-03 2014-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -3.000 43.115 -6,51 272,88 -818.640 11.765.221
2014-01-03 2013-12-31 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -48.000 4.736 -91,02
2014-01-03 2013-12-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -22.007 46.115 -32,31 276,09 -6.075.913 12.731.890
2014-01-03 2013-12-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -5.325 68.122 -7,25 276,09 -1.470.179 18.807.803
2014-01-03 2013-12-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 48.000 73.447 188,63 30,63 1.470.240 2.249.682
2013-12-26 2013-12-24 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -4.705 0 -100,00
2013-12-26 2013-12-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 4.705 25.447 22,68 21,25 99.981 540.749
2013-12-20 2013-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -133 20.742 -0,64 271,09 -36.055 5.622.949
2013-12-20 2013-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -295 0 -100,00
2013-12-20 2013-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -139 20.875 -0,66 264,86 -36.816 5.528.952
2013-12-20 2013-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -23 21.014 -0,11 264,86 -6.092 5.565.768
2013-12-20 2013-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 295 21.037 1,42 21,25 6.269 447.036
2013-12-20 2013-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -9.000 20.742 -30,26 270,20 -2.431.800 5.604.488
2013-12-17 2013-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -8 29.742 -0,03 270,00 -2.160 8.030.340
2013-12-17 2013-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -14.625 43.875 -25,00
2013-12-17 2013-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -8.000 14.079 -36,23
2013-12-17 2013-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -8.000 14.079 -36,23
2013-12-17 2013-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -3.662 29.750 -10,96 272,73 -998.737 8.113.718
2013-12-17 2013-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -898 33.412 -2,62 272,73 -244.912 9.112.455
2013-12-17 2013-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 8.000 34.310 30,41 30,63 245.040 1.050.915
2013-12-17 2013-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -2.588 26.310 -8,96 272,73 -705.825 7.175.526
2013-12-17 2013-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -9.605 28.898 -24,95 272,73 -2.619.572 7.881.352
2013-12-17 2013-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 14.625 38.503 61,25 179,13 2.619.776 6.897.042
2013-12-17 2013-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -3.338 23.878 -12,26 272,73 -910.373 6.512.247
2013-12-17 2013-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -1.526 27.216 -5,31 272,73 -416.186 7.422.620
2013-12-17 2013-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 8.000 28.742 38,57 52,03 416.240 1.495.446
2013-12-17 2013-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 40.000 40.000
2013-12-17 2013-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 48.000 60.736 376,88
2013-01-10 2013-01-09 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -752 4.705 -13,78
2013-01-10 2013-01-09 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -5.000 0 -100,00
2013-01-10 2013-01-09 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 5.000 20.742 31,76 16,80 84.000 348.466
2013-01-10 2013-01-09 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 752 15.742 5,02 21,25 15.980 334.518
2013-01-04 2013-01-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -4.300 14.990 -22,29 183,10 -787.330 2.744.669
2013-01-04 2013-01-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.300 19.290 -10,65 182,29 -419.267 3.516.374
2013-01-04 2013-01-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -6.200 21.590 -22,31 181,51 -1.125.362 3.918.801
2013-01-04 2013-01-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -786 27.790 -2,75 180,83 -142.132 5.025.266
2013-01-04 2013-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -30.000 295 -99,03
2013-01-04 2013-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -12.830 28.576 -30,99 177,82 -2.281.431 5.081.384
2013-01-04 2013-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -3.584 41.406 -7,97 177,82 -637.307 7.362.815
2013-01-04 2013-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 30.000 44.990 200,13 21,25 637.500 956.038
2012-12-20 2012-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.000 14.990 -11,77 171,11 -342.220 2.564.939
2012-12-20 2012-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -4.623 16.990 -21,39 170,44 -787.944 2.895.776
2012-12-20 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -500 21.613 -2,26 183,13 -91.565 3.957.989
2012-12-20 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -100 22.113 -0,45 181,25 -18.125 4.007.981
2012-12-20 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.256 22.213 -5,35 180,62 -226.859 4.012.112
2012-12-20 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.000 23.469 -4,09 179,56 -179.560 4.214.094
2012-12-20 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.200 24.469 -8,25 178,33 -392.326 4.363.557
2012-12-20 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -4.266 26.669 -13,79 177,52 -757.300 4.734.281
2012-12-20 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.034 30.935 -3,23 176,79 -182.801 5.468.999
2012-12-20 2012-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -8.000 22.079 -26,60
2012-12-20 2012-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -16.000 12.736 -55,68
2012-12-20 2012-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -14.248 30.295 -31,99
2012-12-20 2012-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -5.783 31.969 -15,32 178,62 -1.032.959 5.710.303
2012-12-20 2012-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -1.694 37.752 -4,29 178,62 -302.582 6.743.262
2012-12-20 2012-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 14.248 39.446 56,54 21,25 302.770 838.228
2012-12-20 2012-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -6.107 25.198 -19,51 178,62 -1.090.832 4.500.867
2012-12-20 2012-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -2.743 31.305 -8,06 178,62 -489.955 5.591.699
2012-12-20 2012-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 16.000 34.048 88,65 30,63 490.080 1.042.890
2012-12-20 2012-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -2.612 18.048 -12,64 178,62 -466.555 3.223.734
2012-12-20 2012-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -2.330 20.660 -10,13 178,62 -416.185 3.690.289
2012-12-20 2012-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 8.000 22.990 53,37 52,03 416.240 1.196.170
2012-12-17 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 58.500 58.500
2012-12-17 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 30.000 44.543 206,28
2012-11-09 2012-11-08 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -900 14.990 -5,66 139,05 -125.145 2.084.360
2012-11-09 2012-11-08 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -14.244 15.890 -47,27 138,59 -1.974.076 2.202.195
2012-09-20 2012-09-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.000 30.134 -3,21 148,00 -148.000 4.459.832
2012-09-20 2012-09-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -3.200 31.134 -9,32 147,16 -470.912 4.581.679
2012-09-20 2012-09-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.977 34.334 -7,98 146,89 -437.292 5.043.321
2012-09-20 2012-09-18 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -15.000 0 -100,00
2012-09-20 2012-09-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -6.130 37.311 -14,11 148,78 -912.021 5.551.131
2012-09-20 2012-09-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -1.693 43.441 -3,75 148,78 -251.885 6.463.152
2012-09-20 2012-09-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 15.000 45.134 49,78 16,80 252.000 758.251
2012-08-02 2012-08-01 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -4.562 0 -100,00
2012-08-02 2012-08-01 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -10.428 0 -100,00
2012-08-02 2012-08-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 10.428 30.134 52,92 15,64 163.094 471.296
2012-08-02 2012-08-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 4.562 19.706 30,12 21,92 99.999 431.956
2012-07-27 2012-07-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.500 15.144 -14,17 131,07 -327.675 1.984.924
2012-07-27 2012-07-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -4.519 17.644 -20,39 130,40 -589.278 2.300.778
2012-07-27 2012-07-25 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -15.000 15.000 -50,00
2012-07-27 2012-07-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -5.994 22.163 -21,29 126,76 -759.799 2.809.382
2012-07-27 2012-07-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -1.987 28.157 -6,59 126,76 -251.872 3.569.181
2012-07-27 2012-07-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 15.000 30.144 99,05 16,80 252.000 506.419
2012-02-23 2012-02-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.200 15.144 -7,34 98,05 -117.660 1.484.869
2012-02-23 2012-02-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -9.600 16.344 -37,00 97,58 -936.768 1.594.848
2012-02-23 2012-02-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -23.454 25.944 -47,48 96,45 -2.262.138 2.502.299
2012-02-23 2012-02-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -10.800 49.398 -17,94 95,46 -1.030.968 4.715.533
2012-02-23 2012-02-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -4.200 60.198 -6,52 94,71 -397.782 5.701.353
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -25.438 0 -100,00
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -20.000 0 -100,00
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -15.000 30.000 -33,33
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -49.428 0 -100,00
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -5.753 64.398 -8,20 100,32 -577.141 6.460.407
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -2.511 70.151 -3,46 100,32 -251.904 7.037.548
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 15.000 72.662 26,01 16,80 252.000 1.220.722
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -9.158 57.662 -13,71 100,32 -918.731 5.784.652
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -5.558 66.820 -7,68 100,32 -557.579 6.703.382
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 25.438 72.378 54,19 21,92 557.601 1.586.526
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -7.347 46.940 -13,53 100,32 -737.051 4.709.021
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -4.050 54.287 -6,94 100,32 -406.296 5.446.072
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 20.000 58.337 52,17 20,32 406.400 1.185.408
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -18.530 38.337 -32,58 100,32 -1.858.930 3.845.968
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -7.705 56.867 -11,93 100,32 -772.966 5.704.897
2012-02-23 2012-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 49.428 64.572 326,39 15,64 773.054 1.009.906
2009-12-22 2009-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 14.543 14.543
2009-12-22 2009-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
A - Award 5.457 5.457
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)